N/A N=57 Chronic Pain Self-management for Older Adults With Cognitive Impairment: A Randomized Pilot Trial
Chronic Pain · Cognitive Impairment
Primary: Change in Pain Interference — -0.9; 0.2 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=50 The Efficacy of Aerobic Exercise Training on ANS and Endothelial Function in Compensated Cirrhosis
Cirrhosis · Aerobic Exercises · Lifestyle Modification
Primary: Time-domain Heart Rate Variability (HRV) Parameters: SDNN and RMSSD and SDANN — 75.87; 55.13; -4.77; -14.91 milliseconds — p=0.64
Phase 3 N=589 A Study to Evaluate the Efficacy and Safety of Adjunctive Troriluzole in Obsessive-Compulsive Disorder
Obsessive-Compulsive Disorder
Primary: Change From Baseline in the Y-BOCS Total Score in the Baseline Y-BOCS ≥24 Stratification Cohort at Week 8 (Negative Change Indicates Symptom Improvement) — -3.62; -4.59…
N/A N=115 Precision Diets for Diabetes Prevention
Pre Diabetes · Insulin Resistance · Diabetes Mellitus, Type 2
Primary: Change in Glycemic Control as Measured by Change Blood Sugar Values — 88.9; 95.4; 90.8; 96.7 mg/dL — p=<0.001
Phase 3 N=241 A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis
Atopic Dermatitis
Primary: Percentage of Participants Achieving a ≥75% Improvement in the Eczema Area and Severity Index Score (EASI75) at Week 8 — 18.5; 70.0 percentage of participants — p=<0.0001
N/A N=38 Defining Stress REsilience And Mindfulness Effects in Rheumatoid Arthritis
Arthritis, Rheumatoid
Primary: Patient Satisfaction as Assessed by CSQ-8, Adapted for DREAMER Study — 14; 0 Participants
N/A N=1,647 An Innovative Conversational Agent (Quitbot) for Smoking Cessation
Smoking &Amp; Tobacco Cessation
Primary: Number of Participants With 30-day Cigarette Smoking Cessation — 191; 186 Participants — p=0.720
N/A N=167 Parent Resource About Pediatric Clinical Trials
Education
Primary: Change From Baseline in Knowledge About Clinical Trials at Week 3 — 17.48; 17.35 units on a scale — p=.72
Phase 3 N=50 Opiate Suicide Study in Patients With Major Depression
Major Depressive Disorder
Primary: Change in Scale for Suicidal Ideation (SSI) Total Scores Will be Analyzed as the Primary Outcome Measure Using Mixed Effects Models, — 15.2; 15.0; -11.3; -7.7 score on a…
N/A N=225 Effectiveness and Safety of Restylane Contour in the Treatment of Temple Hollowing
Temporal Hollowing
Primary: Responder Rate Based on the Blinded Evaluators' Live Assessment of the Galderma Temple Volume Deficit Scale (GTVDS) — 91.2; 9.1 percentage of participants — p=<0.001
Phase 2 N=10 A Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers
Subcutaneous Fat
Primary: Assess Maximum Analyte Concentration of CBL-514 in Plasma (Cmax) — 137.6; 79.5 ng/mL
N/A N=108 Artificial Intelligent Clinical Decision Support System Simulation Center Study for Technology Acceptance
Gastrointestinal Hemorrhage
Primary: Median Change in Attitudes Towards Machine Learning Algorithms in Clinical Care Using UTAUT — 0.0; 0.0; 0.0; 0.3 units on a scale
N/A N=990 Study to Assess Outcomes in Women Undergoing Either Hysteroscopic Sterilization (Essure®) or Laparoscopic Tubal Sterilization
Contraception
Primary: Proportion of Subjects Reporting AEs of Chronic Lower Abdominal and/or Pelvic Pain After Insertion of Essure System or After Laparoscopic Tubal Sterilization — 39; 28…
Phase 3 N=1,414 A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults
Migraine
Primary: Percentage of Participants With Pain Freedom at 2 Hours Post-dose — 23.2; 14.1 Percentage of participants — p=<0.0001
N/A N=508 Reducing Health Disparities in Childhood Obesity
Obesity
Primary: BMI Age-Sex Specific Z-Score — -.048; .046 z-score